Identification of Lethal Inhibitors and Inhibitor Combinations for Mono-Driver versus Multi-Driver Triple-Negative Breast Cancer Cells

SIMPLE SUMMARY: Triple-negative breast cancers lack estrogen and progesterone receptors and HER2. They lack effective targeted therapies and tend to be more aggressive, with the worst five-year overall survival and a higher rate of recurrence. This study investigates the oncogenic signaling mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Ku, Geng Chia, Chapdelaine, Abygail G., Ayrapetov, Marina K., Sun, Gongqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407008/
https://www.ncbi.nlm.nih.gov/pubmed/36011019
http://dx.doi.org/10.3390/cancers14164027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407008/
https://www.ncbi.nlm.nih.gov/pubmed/36011019
http://dx.doi.org/10.3390/cancers14164027

Ejemplares similares